Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Masterson

Showing results (211-220 of 256) with videos related to

Pageof 26
Sort By:
BJU International|July 26, 2014
The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?M Francesca Monn, Hristos Z Kaimakliotis, K Clint Cary, et al.
Future Oncology (London, England)|February 13, 2015
Three-tiered nodal classification system for bladder cancer: a new proposalJose A Pedrosa, Michael O Koch, Hristos Z Kaimakliotis, et al.
Histopathology|August 14, 2016
Evidence of a dual histogenetic pathway of sacrococcygeal teratomasRobert E Emerson, Chia-Sui Kao, John N Eble, et al.
Urologic Oncology|July 17, 2014
Critical analysis of the 2010 TNM classification in patients with lymph node-positive bladder cancer: influence of lymph node disease burdenJose A Pedrosa, Hristos Z Kaimakliotis, M Francesca Monn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?Isamu Tachibana, Andre Alabd, Yan Tong, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2009
Synthesis of a novel C2/C2'-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction ratePhilip W Howard, Zhizhi Chen, Stephen J Gregson, et al.
Urologic Oncology|March 27, 2021
Clear cell papillary renal cell carcinoma: Characteristics and survival outcomes from a large single institutional seriesJames E Steward, Sean Q Kern, Liang Cheng, et al.
The Journal of Urology|January 3, 2022
Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular CancerHiren V Patel, Arnav Srivastava, Sinae Kim, et al.
The Journal of Urology|April 16, 2017
Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor ThrombusE Jason Abel, Timothy A Masterson, Jose A Karam, et al.
Urologic Oncology|June 24, 2014
Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?Hristos Z Kaimakliotis, M Francesca Monn, K Clint Cary, et al.
Pageof 26

Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
BJU International|July 26, 2014
The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?M Francesca Monn, Hristos Z Kaimakliotis, K Clint Cary, et al.
Future Oncology (London, England)|February 13, 2015
Three-tiered nodal classification system for bladder cancer: a new proposalJose A Pedrosa, Michael O Koch, Hristos Z Kaimakliotis, et al.
Histopathology|August 14, 2016
Evidence of a dual histogenetic pathway of sacrococcygeal teratomasRobert E Emerson, Chia-Sui Kao, John N Eble, et al.
Urologic Oncology|July 17, 2014
Critical analysis of the 2010 TNM classification in patients with lymph node-positive bladder cancer: influence of lymph node disease burdenJose A Pedrosa, Hristos Z Kaimakliotis, M Francesca Monn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?Isamu Tachibana, Andre Alabd, Yan Tong, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2009
Synthesis of a novel C2/C2'-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction ratePhilip W Howard, Zhizhi Chen, Stephen J Gregson, et al.
Urologic Oncology|March 27, 2021
Clear cell papillary renal cell carcinoma: Characteristics and survival outcomes from a large single institutional seriesJames E Steward, Sean Q Kern, Liang Cheng, et al.
The Journal of Urology|January 3, 2022
Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular CancerHiren V Patel, Arnav Srivastava, Sinae Kim, et al.
The Journal of Urology|April 16, 2017
Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor ThrombusE Jason Abel, Timothy A Masterson, Jose A Karam, et al.
Urologic Oncology|June 24, 2014
Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?Hristos Z Kaimakliotis, M Francesca Monn, K Clint Cary, et al.
Pageof 26